Peter Salzmann
Chief Executive Officer at IMMUNOVANT, INC.
Net worth: 29 M $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Yuval Cohen | M | 49 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 11 years |
Alan Holmer | M | 74 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 10 years |
Julia G. Butchko | M | 53 | 5 years | |
Atul Pande | M | 69 |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | 5 years |
Robert Discordia | M | 60 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 6 years |
John Jenkins | M | 66 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 6 years |
Jacques Suzanne | F | 53 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 5 years |
George Migausky | M | 69 |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | 5 years |
David Hochman | M | 48 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 8 years |
Sean Moran | M | 66 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 10 years |
Avery Catlin | M | 75 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 10 years |
Douglas Hughes | M | 62 |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | 5 years |
Marschall Runge | M | 69 | 11 years | |
Yong Ben | M | 50 | 1 years | |
Anne Altmeyer | M | 59 | 2 years | |
Karen Walker | F | 62 | 6 years | |
Eva Barnett | F | 44 | 3 years | |
Mark Levine | M | 51 | 2 years | |
Frank Torti | M | 45 |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | 5 years |
William Kaelin | M | 66 | 12 years | |
Katherine Baicker | M | 52 | 13 years | |
Jamere Jackson | M | 54 | 8 years | |
George Golumbeski | M | 67 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 1 years |
Barbara White | M | 73 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 11 years |
Andrew Fromkin | M | 58 |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | 5 years |
Juan Luciano | M | 62 | 8 years | |
Daniel Skovronsky | M | 50 | 6 years | |
Jennifer Moseley | F | - | - | |
Christina Bertsch | F | - | - | |
Judy Roth | F | - | - | |
Maria Alba | M | - | - | |
Ian Gourley | M | - | - | |
Sheetal Patel | F | - | - | |
Andy Deig | M | - | - | |
Lauren Schrier | F | - | - | |
Chau Cheng | M | - | - | |
Michael Elliott | M | - | 4 years | |
Donald Zakrowski | M | - | 12 years | |
Dominic Smethurst | M | 50 | - | |
Robert Conley | M | - | 7 years | |
Eric Venker | M | 37 | 4 years | |
Jay Stout | M | 61 | 1 years | |
Johna Norton | F | 57 | 7 years | |
William L. Macias | M | 66 | 3 years | |
Ronald DeMattos | M | - | 9 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
John Lechleiter | M | 70 | 38 years | |
Susan Mahony | M | 59 | 18 years | |
Ellen Marram | F | 77 | 17 years | |
Bryce D. Carmine | M | 72 | 29 years | |
Jackson Tai | M | 73 | 10 years | |
Alex Michael Azar | M | 56 | 4 years | |
Pamela Connealy | F | 62 | 2 years | |
Antoine Ezell | M | 55 | 20 years | |
Paris Panayiotopoulos | M | 50 | 3 years | |
Craig Millian | M | 56 | 4 years | |
Ted Jenkins | M | - | 4 years | |
Carolyn Bertozzi | M | 57 | 4 years | |
Jeffrey Balagna | M | 63 | 1 years | |
Jeffrey A. Winton | M | - | 3 years | |
Joshua Smiley | M | 54 | 5 years | |
Frank M. Deane | M | 74 | 26 years | |
Anne Nobles | M | 67 | 22 years | |
Jennifer Fulk | F | - | 7 years | |
Franklyn Prendergast | M | 79 | 22 years | |
Robert A. Armitage | M | 75 | 13 years | |
Derica Rice | M | 59 | 14 years | |
R. Hoover | M | 78 | 9 years | |
Martin Feldstein | M | 84 | 10 years | |
Win Bischoff | M | 81 | 14 years | |
Karen N. Horn | M | 80 | 29 years | |
Jan Lundberg | M | 71 | 8 years | |
Douglas Oberhelman | M | 71 | 7 years | |
Gregory Davis | M | 70 | 20 years | |
Tracy Newbold | F | - | - | |
Jeremy Morgan | M | - | 3 years | |
Kimberly Mathisen, MBA | - | - | 12 years | |
Natalia Novac | F | - | 4 years | |
Hoon-Mo Lee | M | 46 | 2 years | |
Rachael Brake | M | 52 | 3 years | |
Gudarz Davar | M | - | 3 years | |
Mythili Koneru | M | 46 | 4 years | |
Heather Wasserman | M | - | 7 years | |
Manu Chakravarthy | M | 50 | 2 years | |
Sarena S. Lin | F | 53 | - | |
Stephen Curtis | M | - | 1 years | |
Eiry Roberts | M | 60 | 3 years | |
Rita Jain | M | 62 | - | |
Bronwen Mantlo | M | - | 4 years | |
Elaine Sullivan | M | 63 | 3 years | |
Michael R. Meadows | M | - | 35 years | |
Andrew Oxtoby | M | 50 | 4 years | |
Rachel Humphrey | M | 62 | - | |
Richard Ernest Gilbert | M | - | 12 years | |
Thomas Bumol | M | 70 | 35 years | |
Barton Peterson | M | 65 | 8 years | |
Tiffany Olson | F | 64 | 2 years | |
David M. Kendall | M | 62 | 7 years | |
Gregory D. Plowman | M | - | - | |
John Johnson | M | 66 | 3 years | |
Julie Xing | M | 55 | 9 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Bermuda | 5 | 5.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Peter Salzmann
- Personal Network